Similar articles

• Skin eruption 8 days after a single dose of efavirenz-containing combination therapy.

  Yazaki H, Kikuchi Y, Oka S. Yazaki H, et al. Jpn J Infect Dis. 2001 Dec;54(6):246-7. Jpn J Infect Dis. 2001. PMID: 11862010 No abstract available.
• [A "once daily" drug that with proven effectiveness. Efavirenz has successful outcome also in direct comparisons].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2003 Apr 28;145 Spec No 1:12-3. MMW Fortschr Med. 2003. PMID: 15011576 German. No abstract available.
• Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy.

  Tenorio AR, Irlanda IE, Narkiewicz E, Smith KY, Kessler HA, Sha BE. Tenorio AR, et al. AIDS. 2000 Jul 7;14(10):1470-1. doi: 10.1097/00002030-200007070-00031. AIDS. 2000. PMID: 10930173 No abstract available.
• Dose-ranging studies.

  Manion D. Manion D. Int J Clin Pract Suppl. 1999 Jun;103:8-9. Int J Clin Pract Suppl. 1999. PMID: 10622036 Review.
• A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.

  Wolbach J, Capoccia K. Wolbach J, et al. Nurse Pract. 1999 Jun;24(6):81-2, 87-90, 92. Nurse Pract. 1999. PMID: 10431297 Review. No abstract available.